SEC 13F Intelligence

Managers / Q2 2022 · view latest →

Wishbone Management, LP

CIK 0001777734 · 444 WEST LAKE STREET, 49TH FLOOR, CHICAGO, IL, 60606 · 312-265-5560

Reported Value
$275M
Q2 2022
Positions
7
Filings on Record
26
2019–present window
Filed
Aug 15, 2022
original filing

Summary

Wishbone Management, LP reported $275M in U.S.-listed holdings across 7 positions for Q2 2022.

The portfolio is heavily concentrated: MU alone accounts for 23.6% of reported value.

Compared with Q1 2022, the fund opened 0 new positions and exited 2.

Portfolio Metrics

Turnover
+1.2%
vs prior filed quarter
Largest Position
+23.6%
Micron Technology

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’19: $435MQ4 ’19Q1 ’20: $333MQ2 ’20: $404MQ3 ’20: $474MQ4 ’20: $437MQ4 ’20Q1 ’21: $596MQ2 ’21: $648MQ3 ’21: $725MQ4 ’21: $735MQ4 ’21Q1 ’22: $510MQ2 ’22: $275MQ3 ’22: $347MQ4 ’22: $323MQ4 ’22Q1 ’23: $347MQ2 ’23: $334MQ3 ’23: $282MQ4 ’23: $226MQ4 ’23Q1 ’24: $283MQ2 ’24: $310MQ3 ’24: $279MQ4 ’24: $211MQ4 ’24Q1 ’25: $167MQ2 ’25: $221MQ3 ’25: $186MQ4 ’25: $234MQ4 ’25Q1 ’26: $136Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 88.9%Other: 11.1%
  • Common Stock · 88.9% · $244M
  • Other · 11.1% · $31M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
UNHUNITEDHEALTH GROUP INCSOLD OUT−80.0K0−$41M$0
VIPSVIPSHOP HOLDINGS LIMITEDSOLD OUT−4.30M0−$39M$0
UBERUBER TECHNOLOGIES INCADDED+1.35M2.85M+$5M$58M
COMPCOMPASS INCTRIMMED−2.43M5.25M−$41M$19M
WWAYFAIR INCADDED+169.5K900.0K−$42M$39M
AYXEURALTERYX INCTRIMMED−130.0K500.0K−$21M$24M
ELVELEVANCE HEALTH INCTRIMMED−20.0K80.0K−$11M$39M
ARCO PLATFORM LTDTRIMMED−340.1K2.05M−$20M$31M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

7 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MUMICRON TECHNOLOGY INChistory →COM23.56%$65M1.17M
2UBERUBER TECHNOLOGIES INChistory →COM21.24%$58M2.85M
3WWAYFAIR INChistory →CL A14.28%$39M900.0K
4ELVELEVANCE HEALTH INChistory →COM14.06%$39M80.0K
5ARCO PLATFORM LTDCOM CL A11.15%$31M2.05M
6AYXEURALTERYX INChistory →COM CL A8.82%$24M500.0K
7COMPCOMPASS INChistory →CL A6.90%$19M5.25M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$136M4May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$234M5Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M4Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$221M4Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$167M4May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$211M4Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$279M5Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$310M5Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$283M4May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$226M3Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$282M6Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$334M7Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$347M9May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$323M9Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$347M10Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$275M7Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$510M9May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$735M11Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$725M10Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$648M10Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$596M9May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$437M11Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$474M13Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$404M12Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$333M11May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$435M9Feb 14, 202013F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.